Regis Healthcare forecasts FY26 earnings at upper limit of guidance

Grafa
Regis Healthcare forecasts FY26 earnings at upper limit of guidance
Regis Healthcare forecasts FY26 earnings at upper limit of guidance
Brie Carter
Written by Brie Carter
Share

Regis Healthcare Limited (ASX: REG) has announced a third-quarter update, projecting a full-year underlying EBITDA of approximately $135 million.

This puts the aged care provider at the top end of its previous financial guidance, driven by historically high occupancy levels and robust cash generation.

Average occupancy across the group's mature homes reached 95.9% in Q3, bolstered by high market demand and streamlined hospital discharge pathways.

The company’s financial position was further strengthened by $44.5 million in net RAD cash inflows during the quarter, bringing the year-to-date total to $223 million.

Beyond operational performance, Regis recently completed the divestment of two non-core facilities in Far North Queensland, generating a $25 million pre-tax profit.

Management expressed optimism regarding the Federal Government’s recent $3 billion funding package and accommodation pricing review.

CEO Dr. Linda Mellors noted that while specific budget details are pending, the shift toward a more sustainable capital framework supports long-term sector stability and Regis' ongoing growth strategy.

Frequently asked questions

Connect with us

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.